The clinical implications of the Prostate Cancer Prevention Trial
Michael Marberger(Medical University of Vienna), Pierre Teillac(Hôpital Saint-Louis), E. Solsona(Fundación Instituto Valenciano de Oncología), Carlos Rabaça(Instituto Português de Oncologia de Coimbra Francisco Gentil), Domenico Prezioso(Federico II University Hospital), Patricia Fitzpatrick(University College Dublin), D. Kirk, Jan Adolfsson(Karolinska Institutet)
Cited by 25
Related Papers
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group
|Archivio Italiano di Urologia e Andrologia|2015|202
Prevalence, Incidence Estimation, Risk Factors and Characterization of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Urological Hospital Outpatients in Italy: Results of a Multicenter Case-Control Observational Study
|The Journal of Urology|2007|181
Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas
|International Journal of Cancer|1999|97
Italian validation of the International Consultation on Incontinence Questionnaires
|British Journal of Urology|2005|84